Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENSC | APLM | CSCI | ||
| Company | Ensysce Biosciences Inc | Apollomics Inc Cl A | Cosciens Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.01 | 8.65 | 2.71 | ||
| High | 8.59 | 10.50 | 2.74 | ||
| Low | 7.49 | 7.62 | 2.50 | ||
| Last | 8.10 | 9.75 | 2.50 | ||
| Change | +0.15 | +0.38 | -0.29 | ||
| % Change | +1.89% | +4.06% | -10.55% | ||
| Volume | 155,000 | 194,200 | 5,400 | ||
| 20-Day Average Volume | 186,444 | 107,461 | 4,950 | ||
| Previous Close | 7.95 | 9.37 | 2.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 7.22 | 8.81 | 2.88 | ||
| 20-Day Raw Stochastic | 69.70% | 57.92% | 0.00% | ||
| 20-Day Relative Strength | 53.09% | 48.36% | 33.66% | ||
| Weighted Alpha | -73.84 | -85.25 | -64.55 | ||
| Today's Opinion | 24% Buy | 88% Sell | 100% Sell | ||
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 40% Buy | 56% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +44.13% since 12/13/24 | +16.90% since 12/13/24 | -13.79% since 12/12/24 | ||
| Low | 5.58 on 12/16/24 | 7.23 on 12/18/24 | 2.50 on 12/20/24 | ||
| High | 8.81 on 12/19/24 | 10.50 on 12/20/24 | 2.99 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -17.65% since 11/20/24 | -34.91% since 11/20/24 | -16.13% since 11/20/24 | ||
| Low | 5.34 on 12/13/24 | 6.50 on 12/10/24 | 2.50 on 12/20/24 | ||
| High | 9.82 on 11/21/24 | 12.25 on 11/21/24 | 3.20 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | +67.60% since 09/20/24 | -24.54% since 09/20/24 | -39.51% since 09/20/24 | ||
| Low | 2.12 on 10/15/24 | 6.50 on 12/10/24 | 2.50 on 12/20/24 | ||
| High | 14.67 on 11/07/24 | 35.98 on 11/18/24 | 4.02 on 09/24/24 | ||
| 6-Month | |||||
| %Chg | -1.01% since 06/20/24 | -50.08% since 06/20/24 | -45.89% since 06/20/24 | ||
| Low | 2.12 on 10/15/24 | 6.50 on 12/10/24 | 2.50 on 12/20/24 | ||
| High | 14.67 on 11/07/24 | 35.98 on 11/18/24 | 7.54 on 07/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,575 | 10,594 | 9,397 | ||
| Shares Outstanding, K | 1,306 | 1,087 | 3,759 | ||
| Annual Sales | 2,230,000 | 1,220,000 | 4,500,000 | ||
| Annual Net Income | -10,610,000 | -172,600,000 | -16,550,000 | ||
| Last Quarter Sales | 3,420,000 | N/A | 1,870,000 | ||
| Last Quarter Net Income | 660,000 | N/A | -5,760,000 | ||
| 60-Month Beta | 0.60 | 1.09 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.05 on 11/12/24 | N/A | -1.85 on 11/12/24 | ||
| Latest Earnings Date | 11/14/24 | 06/27/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||